Skip to main content
Contact Us
Subscribe
E-Edition
39°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
2025 Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Edwards Lifesciences
(NY:
EW
)
70.38
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EST, Nov 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Edwards Lifesciences
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
15
16
Next >
$1000 Invested In This Stock 10 Years Ago Would Be Worth $7,400 Today
June 08, 2023
Via
Benzinga
Illumina Takes AI to Genomics: Launch of PrimateAI-3D for Accurate Disease Prediction
June 02, 2023
Illumina, Inc. (NASDAQ: ILMN) launched PrimateAI-3D, an artificial intelligence (AI) algorithm that predicts disease-causing genetic mutations in patients.
Via
Benzinga
The Latest Analyst Ratings for Edwards Lifesciences
May 30, 2023
Via
Benzinga
$100 Invested In This Stock 10 Years Ago Would Be Worth $800 Today
May 24, 2023
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
May 12, 2023
Via
Benzinga
Will Investors Notice Exciting Sign On Edwards Lifesciences's Chart?
May 11, 2023
Via
Benzinga
Here's How Much $1000 Invested In Edwards Lifesciences 10 Years Ago Would Be Worth Today
May 09, 2023
Via
Benzinga
Piper Sandler Maintains Neutral Rating for Edwards Lifesciences: Here's What You Need To Know
April 27, 2023
Via
Benzinga
This Is What Whales Are Betting On Edwards Lifesciences
April 26, 2023
Via
Benzinga
The Latest Analyst Ratings for Edwards Lifesciences
April 24, 2023
Via
Benzinga
Here's How Much You Would Have Made Owning Edwards Lifesciences Stock In The Last 5 Years
April 24, 2023
Via
Benzinga
3 Medical Device Stocks Outpacing the Healthcare Industry This Year
May 01, 2023
All three of these companies have seen double-digit increases in their share prices this year.
Via
The Motley Fool
Market Rally Wobbles Amid Big Earnings Moves From Microsoft, Meta, Crocs, Cloudflare: Weekly Review
April 28, 2023
Microsoft, Meta, Cloudflare and Crocs were among the many big movers.
Via
Investor's Business Daily
10 Health Care Stocks With Whale Alerts In Today's Session
April 27, 2023
Via
Benzinga
The Latest Analyst Ratings for Edwards Lifesciences
March 29, 2023
Via
Benzinga
Looking Into Edwards Lifesciences's Recent Short Interest
March 15, 2023
Via
Benzinga
Expert Ratings for Edwards Lifesciences
March 08, 2023
Via
Benzinga
Edwards Lifesciences Stock Jumps After Beating Fourth-Quarter Views
January 31, 2023
The company expects full-year sales to grow 9%-12% in constant currency.
Via
Investor's Business Daily
10 Health Care Stocks With Whale Alerts In Today's Session
April 26, 2023
Via
Benzinga
eBay To Rally Around 30%? Here Are 10 Other Analyst Forecasts For Tuesday
April 25, 2023
B of A Securities cut the price target for Catalent, Inc. (NYSE: CTLT) from $78 to $49. B of A Securities analyst Derik De Bruin maintained a Neutral rating. Catalent shares fell 0.2% to $44.83 in...
Via
Benzinga
3 No-Brainer Medical Device Stocks to Buy Right Now
April 06, 2023
These companies have consistently delivered revenue and EPS gains.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For March 8, 2023
March 08, 2023
Via
Benzinga
Here's How Much $1000 Invested In Edwards Lifesciences 10 Years Ago Would Be Worth Today
January 31, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 29, 2023
March 29, 2023
Via
Benzinga
Interview With David Rolfe of Wedgewood Partners
February 17, 2023
Motley Fool analyst John Rotonti recently seized the opportunity to interview David Rolfe.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For February 6, 2023
February 06, 2023
Via
Benzinga
Buy/Sell: Wall Street's Top 10 Stock Calls This Week - Saturday, Feb. 4
February 04, 2023
What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street’s best analysts during the week of Jan. 30 through Feb. 3.
Via
Talk Markets
Edwards Lifesciences Q4 Earnings Beats Street Estimates, Expects Easing Of Macro Headwinds Later In 2023
February 01, 2023
Via
Benzinga
2 Top Dividend Growth Stocks to Buy in February
February 01, 2023
They don't offer the highest yields, but these strongly profitable businesses are poised to raise their payouts at a blistering pace.
Via
The Motley Fool
Earnings Scheduled For January 31, 2023
January 31, 2023
Companies Reporting Before The Bell • Biophytis (NASDAQ:BPTS) is projected to report earnings for its first quarter.
Via
Benzinga
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
15
16
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.